Advertisement

Reactions Weekly

, Volume 1733, Issue 1, pp 254–254 | Cite as

Mycophenolate mofetil/valganciclovir

Cytomegalovirus infection secondary to myelosuppression: 24 case reports
Case report
  • 20 Downloads

Reference

  1. Eriksson M, et al. Low-dose valganciclovir prohylaxis is efficacious and safe in cytomegalovirus seropositive heart transplant recipients with anti-thymocyte globulin. Transplant Infectious Disease 20: e12868, No. 3, Jun 2018. Available from: URL: http://doi.org/10.1111/tid.12868 - Finland

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations